| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Yen Yun serves as a Director at LIXT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $250K at current prices.
The biggest single holding is LIXT (~$250K). Net of sales, the recent Form 4 record there shows accumulation of 52,632 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | LIXT Lixte Biotechnology Holdings, Inc. | - | Buy | 52,632 | $4.75 | $250,002.00 | New |